QGQiaoyu Gong

Qiaoyu Gong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Qiaoyu Gong has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Huadong Zhao

    Department of Neurology, The Third Xiangya Hospital Central South University Changsha China

    1 shared publication
  • Jun Liu

    Department of Radiology, the Third Xiangya Hospital Central South University Changsha China

    1 shared publication
  • Lei Liu

    Health Management Medical Center, The Third Xiangya Hospital, Central South University, Changsha, China

    1 shared publication
  • Mengli Wang

    Department of Neurology, The Third Xiangya Hospital Central South University Changsha China

    1 shared publication
  • Pengfei Rong

    Department of Radiology, the Third Xiangya Hospital Central South University Changsha China

    1 shared publication
  • Ruxu Zhang

    Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, China

    1 shared publication

Latest Publications

  • Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation

    by Zhongzheng Li, Sen Zeng, Yongzhi Xie, Xiaobo Li, Shunxiang Huang, Huadong Zhao, Wanqian Cao, Lei Liu, Mengli Wang, Qiaoyu Gong, et al.

    Background and Aims: Mutations in ganglioside‐induced differentiation‐associated protein 1 (GDAP1) cause axonal or demyelinating Charcot–Marie–Tooth disease (CMT) with autosomal dominant or recessive inheritance. In this study, we aim to report the genotypic and phenotypic features of GDAP1‐related CMT in a Chinese cohort.Methods: Clinical, neurophysiological, genetic data, and available muscle/brain imaging information of 28 CMT patients with GDAP1 variants were retrospectively collected.Results: We identified 16 GDAP1 pathogenic variants, among which two novel variants c.980dup(p.L328FfsX25) and c.480+4T>G were first reported. Most patients (16/28) presented with AR or AD CMT2K phenotype. Clinical characteristics in our cohort demonstrated that the AR patients presented earlier onset, more severe phenotype compared with the AD patients. Considerable intra‐familial phenotypic variability was observed among three AD families. Muscle atrophy and fatty infiltration in the lower extremity were detected by Muscle magnetic resonance imaging (MRI) scans in four patients. MRI showed two AR patients showed more severe muscle involvement of the posterior compartment than those of the anterolateral compartment in the calf. One patient carrying Q38*/H256R variants accompanied with mild periventricular leukoaraiosis.Conclusions: In this study, we conducted an analysis of clinical features of the GDAP1‐related CMT patients, expanded the mutation spectrum in GDAP1 by reporting two novel variants, and presented the prevalent occurrence of the H256R mutation in China. The screening of GDAP1 should be particularly emphasized in Chinese patients with CMT2, given the incomplete penetrance and pathogenic inheritance patterns involving dominant and recessive modes.